Lincoln pharmaceuticals Weekly CMP 269 Target 305 Stop 235 1) Reverse H & S observed. 2) Neckline resistance breakout observed at 203. 3) Stock cleared past major resistance at 255 and has potential to reach 300-305 levels. 4) At 300-305 levels need a review as resistance observed. 5) A decisive cross above 310 could lead to an uncharted territory.